Arrhythmia Research Technology (HRT) Reports Q1 EPS of $0.04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.36 --0%
Financial Fact:
Other income (expense), net: -69.39K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Other income (expense), net: -69.39K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Arrhythmia Research Technology (NYSE: HRT) reported Q1 EPS of $0.04, versus $0.09 reported last year. Revenue for the quarter came in at $5.06 million, versus $6.03 million reported last year.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- McDonald's posts better-than-expected third-quarter comparable sales
- Helen of Troy rejects $37-per-share takeover bid from Spectrum Brands
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
